Biography and Research Information
OverviewAI-generated summary
Paras Malik's research centers on various aspects of health and disease, with a notable focus on retrospective analyses and systematic reviews of clinical data. His work includes investigating treatment outcomes for conditions such as pulmonary hypertension and COVID-19, examining the safety and efficacy of pharmacological agents like Remdesivir, and exploring the role of specific biomarkers in different cancer types. Malik has also contributed to understanding the epidemiology of rare diseases, including aggressive NK-cell leukemia and heavy chain disease in the United States. His publications address a range of medical topics, from acquired hemophilia A in the context of vaccination to the re-emergence of scurvy in contemporary society. With an h-index of 10 and over 1,200 citations across 56 publications, Malik has established a significant body of work in clinical and public health research.
Metrics
- h-index: 10
- Publications: 56
- Citations: 1,257
Selected Publications
-
Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC) (2025)
-
CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma (2025)
-
POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma (2025)
-
Scurvy in the Modern World: Extinct or Not? (2022)
Collaboration Network
Top Collaborators
- Scurvy in the Modern World: Extinct or Not?
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
- POSTER: CLL-623 Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- CLL-623: Outcomes of Patients With Concurrent Chronic Lymphocytic Leukemia and Non-Small Cell Lung Carcinoma
- Scurvy in the Modern World: Extinct or Not?
- Scurvy in the Modern World: Extinct or Not?
- Scurvy in the Modern World: Extinct or Not?
- Scurvy in the Modern World: Extinct or Not?
- Outcomes of patients with concurrent Chronic Lymphocytic leukemia (CLL) and Non-small cell lung carcinoma (NSCLC)
Similar Researchers
Based on overlapping research topics